Publication Name	World Journal of Cardiology
Manuscript ID	19963
Country	France

Received	2015-05-27 10:23
Peer-Review Started	2015-05-29 08:33
First Decision by Editorial Office Director
Return for Revision	2015-08-04 10:14
Revised	2015-08-16 20:26
Publication Fee Transferred
Second Decision by Editor	2015-09-02 15:46
Second Decision by Editor-in-Chief	2015-09-05 16:08
Final Decision by Editorial Office Director	2015-09-16 18:50
Articles in Press	2015-09-16 18:50
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-12 16:32
Publish the Manuscript Online	2015-11-03 08:25

ISSN	1949-8462 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	Is there a rationale for short cardioplegia re-dosing intervals?
Manuscript Source	Invited Manuscript
All Author List	Yves D Durandy
Funding Agency and Grant Number
Corresponding Author	Yves D Durandy, MD, Consultant, Department of Intensive Care and Perfusion, Centre Chirurgical Marie Lannelongue, Avenue de la Résistance, F-92350 Le Plessis, Robinson, France. yves.durandy@gmail.com
Key Words	Myocardial protection; Del Nido cardioplegia; Continuous cardioplegia; Intermittent cardioplegia; Single-shot cardioplegia; Multidose cardioplegia; Crystalloid cardioplegia; Blood cardioplegia; Custodiol®; Histidine-ketoglutarate-tryptophan
Core Tip	During myocardial ischemia, cardioplegia is the preferred method of myocardial protection. However, decades after its implementation, there is still no consensus on the optimal re-dosing interval. Shorter re-dosing (15-30 min) has been preferred to longer intervals (45-60 min), but the choice of one approach over another relies more on the surgeon’s preference than on clear advantages. As the interest for one-shot cardioplegia has been increasing recently, we intend to discuss the rationale, if any, for short cardioplegia re-dosing interval.
Publish Date	2015-11-03 08:25
Citation	Durandy YD. Is there a rationale for short cardioplegia re-dosing intervals? World J Cardiol 2015; 7(10): 658-664
URL	http://www.wjgnet.com/1949-8462/full/v7/i10/658.htm
DOI	http://dx.doi.org/10.4330/wjc.v7.i10.658

Full Article (PDF)	WJC-7-658.pdf
Full Article (Word)	WJC-7-658.doc
Manuscript File	19963-Review.docx
Answering Reviewers	19963-Answering reviewers.pdf
Audio Core Tip	19963-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19963-Conflict-of-interest statement.pdf
Copyright License Agreement	19963-Copyright assignment.pdf
Peer-review Report	19963-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	19963-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	19963-Scientific misconduct check.pdf
Scientific Editor Work List	19963-Scientific editor work list.pdf